[Is lymphoma curable with antibody therapy?].

Abstract

Diagnostics of non-Hodgkin's lymphomas has improved significantly over the last decades. Predictors have been found and new biological therapies developed. Rituximab, an antibody recognizing the CD20 B cell antigen, has proven to be of especially high clinical importance. In a proportion of follicular lymphomas, long responses are achieved with rituximab… (More)

Topics

Cite this paper

@article{Lepp2009IsLC, title={[Is lymphoma curable with antibody therapy?].}, author={Sirpa Lepp{\"a} and Heidi Nyman and Marja-Liisa Karjalainen-Lindsberg}, journal={Duodecim; laaketieteellinen aikakauskirja}, year={2009}, volume={125 3}, pages={267-73} }